513 related articles for article (PubMed ID: 8664521)
21. Clinical outcomes during the first three months posttransplant in renal allograft recipients managed by C2 monitoring of cyclosporine microemulsion.
Thervet E; Pfeffer P; Scolari MP; Toselli L; Pallardó LM; Chadban S; Pilmore H; Connolly J; Buchler M; Schena FP; Carreño CA; Dandavino R; Cole E
Transplantation; 2003 Sep; 76(6):903-8. PubMed ID: 14508352
[TBL] [Abstract][Full Text] [Related]
22. Randomized study comparing cyclosporine with azathioprine one year after renal transplantation-15-year outcome data.
Joss N; Rodger RS; McMillan MA; Junor BJ
Transplantation; 2007 Mar; 83(5):582-7. PubMed ID: 17353778
[TBL] [Abstract][Full Text] [Related]
23. Renal allograft immunosuppression. IV. Comparison of lipid and lipoprotein profiles in blood using double and triple immunosuppressive drug combinations.
Isoniemi H; Tikkanen MJ; Ahonen J; Häyry P
Transpl Int; 1991 Sep; 4(3):130-5. PubMed ID: 1958276
[TBL] [Abstract][Full Text] [Related]
24. [Withdrawal of prednisone from a triple combination of immunosuppressive agents after kidney transplantation].
Matl I; Lácha J; Lodererová A; Símová M; Teplan V; Lánská V; Vítko S
Cas Lek Cesk; 2000 Mar; 139(4):115-9. PubMed ID: 10838741
[TBL] [Abstract][Full Text] [Related]
25. A comparison of discharge immunosuppressive drug regimens in primary cadaveric kidney transplantation.
Cherikh WS; Myron Kauffman H; Maghirang J; Bleyer AJ; Johnson CP
Transplantation; 2003 Aug; 76(3):463-70. PubMed ID: 12923430
[TBL] [Abstract][Full Text] [Related]
26. A randomized trial comparing triple-drug and double-drug therapy in renal transplantation. Analysis at 7 years.
Montagnino G; Tarantino A; Banfi G; Aroldi A; Cesana B; Ponticelli C
Transplantation; 1994 Jul; 58(2):149-54. PubMed ID: 8042234
[TBL] [Abstract][Full Text] [Related]
27. Conversion from calcineurin inhibitors to sirolimus maintenance therapy in renal allograft recipients: 24-month efficacy and safety results from the CONVERT trial.
Schena FP; Pascoe MD; Alberu J; del Carmen Rial M; Oberbauer R; Brennan DC; Campistol JM; Racusen L; Polinsky MS; Goldberg-Alberts R; Li H; Scarola J; Neylan JF;
Transplantation; 2009 Jan; 87(2):233-42. PubMed ID: 19155978
[TBL] [Abstract][Full Text] [Related]
28. Treatment of steroid-resistant and recurrent acute cardiac transplant rejection with a short course of antibody therapy.
Cantarovich M; Latter DA; Loertscher R
Clin Transplant; 1997 Aug; 11(4):316-21. PubMed ID: 9267721
[TBL] [Abstract][Full Text] [Related]
29. Early cyclosporine monotherapy in liver transplantation: a 5-year follow-up of a prospective, randomized trial.
Belli LS; de Carlis L; Rondinara G; Alberti AB; Bellati G; De Gasperi A; Forti D; Idèo G
Hepatology; 1998 Jun; 27(6):1524-9. PubMed ID: 9620322
[TBL] [Abstract][Full Text] [Related]
30. A retrospective study of conversion from tacrolimus-based to sirolimus-based immunosuppression in orthotopic liver transplant recipients.
Yu S; He X; Yang L; Ma Y; Zhu X; Ju W; Huang J
Exp Clin Transplant; 2008 Jun; 6(2):113-7. PubMed ID: 18816237
[TBL] [Abstract][Full Text] [Related]
31. Beneficial effect of concomitant induction with antilymphoblast globulin, cyclosporine, and steroids on long-term renal allograft outcome.
Koga A; Moreso FJ; Seron D; Gil-Vernet S; Cruzado JM; Castelao AM; Grinyó JM
Transplant Proc; 2004 Jun; 36(5):1305-7. PubMed ID: 15251318
[TBL] [Abstract][Full Text] [Related]
32. Renal allograft function and histology in children on triple immunosuppression based on individual pharmacokinetically determined cyclosporine administration.
Laine J; Hoppu K; Holmberg C
Transplant Proc; 1994 Oct; 26(5):2775-6. PubMed ID: 7940874
[No Abstract] [Full Text] [Related]
33. Five-year follow-up of a randomized double-drug versus triple-drug therapy immunosuppressive trial after heart transplantation.
Keogh A; Macdonald P; Mundy J; Chang V; Harvison A; Spratt P
J Heart Lung Transplant; 1992; 11(3 Pt 1):550-5; discussion 556. PubMed ID: 1610863
[TBL] [Abstract][Full Text] [Related]
34. A randomized study comparing three cyclosporine-based regimens in cadaveric renal transplantation. Italian Multicentre Study Group for Renal Transplantation (SIMTRe).
Ponticelli C; Tarantino A; Segoloni GP; Cambi V; Rizzo G; Altieri P; Mastrangelo F; Castagneto M; Salvadori M; Valente U; Cossu M; Federico S; Pisani F; Montagnino G; Messina M; Arisi L; Carmellini M; Piredda G; Corbetta G
J Am Soc Nephrol; 1997 Apr; 8(4):638-46. PubMed ID: 10495794
[TBL] [Abstract][Full Text] [Related]
35. OKT3 prophylaxis versus conventional drug therapy: single-center perspective, part of a multicenter trial.
Kahana L; Narvarte J; Ackermann J; LeFor W; Weinstein S; Wright C; deQuesada A; Baxter J; Shires D
Am J Kidney Dis; 1989 Nov; 14(5 Suppl 2):5-9. PubMed ID: 2510510
[TBL] [Abstract][Full Text] [Related]
36. A prospective randomized trial of pretransfusion/azathioprine/prednisone versus cyclosporine/prednisone immunosuppression in cardiac transplant recipients: preliminary results.
Barnhart GR; Hastillo A; Goldman MH; Szentpetery S; Wolfgang TC; Mohanakumar T; Katz MR; Rider S; Hanrahan J; Lower RR
Circulation; 1985 Sep; 72(3 Pt 2):II227-30. PubMed ID: 3896555
[TBL] [Abstract][Full Text] [Related]
37. Triple-drug immunosuppression with steroid discontinuation by six months after heart transplantation.
Olivari MT; Jessen ME; Baldwin BJ; Horn VP; Yancy CW; Ring WS; Rosenblatt RL
J Heart Lung Transplant; 1995; 14(1 Pt 1):127-35. PubMed ID: 7727461
[TBL] [Abstract][Full Text] [Related]
38. Impacts of low-dose steroids and prophylactic monoclonal versus polyclonal antibodies on acute rejection in cyclosporine- and azathioprine-immunosuppressed cardiac allografts.
Laufer G; Laczkovics A; Wollenek G; Schreiner W; Sochor H; Holzinger C; Buchelt M; Fasol R; Wolner E
J Heart Transplant; 1989; 8(3):253-61. PubMed ID: 2661776
[TBL] [Abstract][Full Text] [Related]
39. Comparison of three immunosuppressive regimens in cadaver renal transplantation: long-term cyclosporine, short-term cyclosporine followed by azathioprine and prednisolone, and azathioprine and prednisolone without cyclosporine.
Hall BM; Tiller DJ; Hardie I; Mahony J; Mathew T; Thatcher G; Miach P; Thomson N; Sheil AG
N Engl J Med; 1988 Jun; 318(23):1499-507. PubMed ID: 3285215
[TBL] [Abstract][Full Text] [Related]
40. De novo cancer in cyclosporine-treated and non-cyclosporine-treated adult primary renal allograft recipients.
Gruber SA; Gillingham K; Sothern RB; Stephanian E; Matas AJ; Dunn DL
Clin Transplant; 1994 Aug; 8(4):388-95. PubMed ID: 7949545
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
